Aromatase inhibitors induce ‘male pattern hair loss’ in women?

Aromatase inhibitors induce 'male pattern hair loss' in women?

Female androgenetic alopecia (FAGA) is a common and distressing cause of hair loss, caused by androgens in genetically susceptible women [1, 2], in which dihydrotestosterone (DHT) binds to androgen receptors leading to miniaturization of scalp hair follicles [3]. FAGA, characterized by a specific diffuse loss of hair of the parietal or frontovertical regions ('in the crown'), where 5α-reductase...

Evaluation and treatment of male and female pattern hair loss

Diffuse hair loss in women in Ahwaz

Background: Diffuse hair loss is one of the most common complaints of women attending skin clinics. Objective: The purpose of this study was to evaluate diffuse hair loss in women referring to a private office. Patients and Methods: This descriptive, retrospective study was performed on women attending a private skin clinic in Ahwaz complaining of diffuse hair loss. The study was done for 10 mo...

Aromatase Inhibitors and Bone Loss

The aromatase inhibitors (AIs) anastrozole (Arimidex), letrozole (Femara), and exemestane (Aromasin) are significantly more effective than the selective estrogen-receptor modulator (SERM) tamoxifen in preventing recurrence in estrogen receptor-positive early breast cancer. Aromatase inhibitors are likely to replace SERMs as first-line adjuvant therapy for many patients. However, AIs are associa...

Aromatase inhibitors and bone loss.

The aromatase inhibitors (AIs) anastrozole (Arimidex), letrozole (Femara), and exemestane (Aromasin) are significantly more effective than the selective estrogen-receptor modulator (SERM) tamoxifen in preventing recurrence in estrogen receptor-positive early breast cancer. Aromatase inhibitors are likely to replace SERMs as first-line adjuvant therapy for many patients. However, AIs are associa...